ID

19654

Beschrijving

Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98; ODM derived from: https://clinicaltrials.gov/show/NCT00899288

Link

https://clinicaltrials.gov/show/NCT00899288

Trefwoorden

  1. 19-01-17 19-01-17 -
  2. 02-09-21 02-09-21 -
Geüploaded op

19 januari 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT00899288

Eligibility Breast Cancer NCT00899288

Criteria
Beschrijving

Criteria

enrolled on protocol ibcsg-1-98
Beschrijving

Enrollment

Datatype

boolean

Alias
UMLS CUI [1]
C1516879
currently receiving (i.e., have not yet completed) 5 years of treatment with tamoxifen or letrozole and expected to receive ≥ 6 months of additional treatment on protocol ibcsg-1-98
Beschrijving

Tamoxifen | letrozole | Additional Therapy Expected

Datatype

boolean

Alias
UMLS CUI [1]
C0039286
UMLS CUI [2]
C0246421
UMLS CUI [3,1]
C1706712
UMLS CUI [3,2]
C1517001
no recurrent breast cancer or second primary cancer
Beschrijving

Breast cancer recurrent | Second Primary Cancers

Datatype

boolean

Alias
UMLS CUI [1]
C0278493
UMLS CUI [2]
C0751623
no known bone disease (including osteomalacia or osteogenesis imperfecta)
Beschrijving

Bone Diseases | Osteomalacia | Osteogenesis Imperfecta

Datatype

boolean

Alias
UMLS CUI [1]
C0005940
UMLS CUI [2]
C0029442
UMLS CUI [3]
C0029434
hormone receptor status
Beschrijving

Hormone Receptor Status

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
estrogen and/or progesterone receptor positive tumor
Beschrijving

Estrogen receptor positive tumor | Progesterone receptor positive tumor

Datatype

boolean

Alias
UMLS CUI [1]
C1562312
UMLS CUI [2]
C1562928
patient characteristics:
Beschrijving

Client Characteristics

Datatype

boolean

Alias
UMLS CUI [1]
C0815172
female
Beschrijving

Gender

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
postmenopausal
Beschrijving

Postmenopausal state

Datatype

boolean

Alias
UMLS CUI [1]
C0232970
no uncontrolled thyroid or parathyroid disease, cushing's disease, or other pituitary diseases
Beschrijving

Thyroid Disease Uncontrolled | Parathyroid Disease Uncontrolled | Cushing's disease | Pituitary Diseases

Datatype

boolean

Alias
UMLS CUI [1,1]
C0040128
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0030517
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0221406
UMLS CUI [4]
C0032002
no malabsorption syndrome or clinically relevant vitamin d deficiency
Beschrijving

Malabsorption Syndrome | Vitamin D Deficiency Relevant Clinical

Datatype

boolean

Alias
UMLS CUI [1]
C0024523
UMLS CUI [2,1]
C0042870
UMLS CUI [2,2]
C2347946
UMLS CUI [2,3]
C0205210
prior concurrent therapy:
Beschrijving

Therapeutic procedure

Datatype

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Beschrijving

disease characteristic

Datatype

boolean

Alias
UMLS CUI [1]
C0599878
more than 1 year since prior and no concurrent anticonvulsants
Beschrijving

Anticonvulsants

Datatype

boolean

Alias
UMLS CUI [1]
C0003286
more than 6 months since prior and no concurrent corticosteroids at doses > the equivalent of 5 mg/day of prednisone for > 2 weeks total
Beschrijving

Adrenal Cortex Hormones Dose | Prednisone U/day

Datatype

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0178602
UMLS CUI [2,1]
C0032952
UMLS CUI [2,2]
C0456683
no prior or concurrent sodium fluoride at daily doses ≥ 5 mg/day for > 1 month
Beschrijving

Sodium Fluoride Dose U/day

Datatype

boolean

Alias
UMLS CUI [1,1]
C0037508
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0456683
more than 12 months since prior and no concurrent anabolic steroids
Beschrijving

Anabolic steroids

Datatype

boolean

Alias
UMLS CUI [1]
C0002744
more than 6 months since any prior drug for the prevention of osteoporosis (excluding calcium or cholecalciferol [vitamin d])
Beschrijving

Pharmaceutical Preparations Prevention Osteoporosis | Calcium | Cholecalciferol | Vitamin D

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C2700409
UMLS CUI [1,3]
C0029456
UMLS CUI [2]
C0006675
UMLS CUI [3]
C0008318
UMLS CUI [4]
C0042866
concurrent warfarin allowed provided duration of treatment is no more than 4 weeks
Beschrijving

Warfarin

Datatype

boolean

Alias
UMLS CUI [1]
C0043031

Similar models

Eligibility Breast Cancer NCT00899288

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Enrollment
Item
enrolled on protocol ibcsg-1-98
boolean
C1516879 (UMLS CUI [1])
Tamoxifen | letrozole | Additional Therapy Expected
Item
currently receiving (i.e., have not yet completed) 5 years of treatment with tamoxifen or letrozole and expected to receive ≥ 6 months of additional treatment on protocol ibcsg-1-98
boolean
C0039286 (UMLS CUI [1])
C0246421 (UMLS CUI [2])
C1706712 (UMLS CUI [3,1])
C1517001 (UMLS CUI [3,2])
Breast cancer recurrent | Second Primary Cancers
Item
no recurrent breast cancer or second primary cancer
boolean
C0278493 (UMLS CUI [1])
C0751623 (UMLS CUI [2])
Bone Diseases | Osteomalacia | Osteogenesis Imperfecta
Item
no known bone disease (including osteomalacia or osteogenesis imperfecta)
boolean
C0005940 (UMLS CUI [1])
C0029442 (UMLS CUI [2])
C0029434 (UMLS CUI [3])
Hormone Receptor Status
Item
hormone receptor status
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Estrogen receptor positive tumor | Progesterone receptor positive tumor
Item
estrogen and/or progesterone receptor positive tumor
boolean
C1562312 (UMLS CUI [1])
C1562928 (UMLS CUI [2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Gender
Item
female
boolean
C0079399 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
Thyroid Disease Uncontrolled | Parathyroid Disease Uncontrolled | Cushing's disease | Pituitary Diseases
Item
no uncontrolled thyroid or parathyroid disease, cushing's disease, or other pituitary diseases
boolean
C0040128 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0030517 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0221406 (UMLS CUI [3])
C0032002 (UMLS CUI [4])
Malabsorption Syndrome | Vitamin D Deficiency Relevant Clinical
Item
no malabsorption syndrome or clinically relevant vitamin d deficiency
boolean
C0024523 (UMLS CUI [1])
C0042870 (UMLS CUI [2,1])
C2347946 (UMLS CUI [2,2])
C0205210 (UMLS CUI [2,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
disease characteristic
Item
see disease characteristics
boolean
C0599878 (UMLS CUI [1])
Anticonvulsants
Item
more than 1 year since prior and no concurrent anticonvulsants
boolean
C0003286 (UMLS CUI [1])
Adrenal Cortex Hormones Dose | Prednisone U/day
Item
more than 6 months since prior and no concurrent corticosteroids at doses > the equivalent of 5 mg/day of prednisone for > 2 weeks total
boolean
C0001617 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0032952 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Sodium Fluoride Dose U/day
Item
no prior or concurrent sodium fluoride at daily doses ≥ 5 mg/day for > 1 month
boolean
C0037508 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Anabolic steroids
Item
more than 12 months since prior and no concurrent anabolic steroids
boolean
C0002744 (UMLS CUI [1])
Pharmaceutical Preparations Prevention Osteoporosis | Calcium | Cholecalciferol | Vitamin D
Item
more than 6 months since any prior drug for the prevention of osteoporosis (excluding calcium or cholecalciferol [vitamin d])
boolean
C0013227 (UMLS CUI [1,1])
C2700409 (UMLS CUI [1,2])
C0029456 (UMLS CUI [1,3])
C0006675 (UMLS CUI [2])
C0008318 (UMLS CUI [3])
C0042866 (UMLS CUI [4])
Warfarin
Item
concurrent warfarin allowed provided duration of treatment is no more than 4 weeks
boolean
C0043031 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial